Building Annex 1 readiness into primary packaging
Packaging component design, manufacturing controls, and supplier evidence help pharmaceutical manufacturers strengthen contamination prevention from development through to sterile filling.
Sponsored
Australia’s largest early-phase clinical trial network expands to Sydney
How Kenya has become a clinical logistics hub for sub-Saharan Africa
Seeing the full patient journey
Transitioning from lab bench to GMP: What research scientists should know about manual aseptic filling
Retatrutide peptide: A quality-control checklist for sourcing research-grade material
Pharma’s supplier sprawl problem: When more vendors create less control
Can smarter technology selection help de-risk small-molecule development?
